Time course of appearance and release of [35S]cysteine labelled neurophysins and peptides in the neurohypophysis.
[35S]cysteine injected adjacent to the supraoptic nuclei (SON) of rats is rapidly incorporated into two macromolecular (both about 20,000 Daltons) common precursors of arginine vasopressin (AVP) and its associated neurophysin, and oxytocin (OT) and its neurophysin. Conversion of the larger precursor proteins to the smaller peptides appears to occur intragranularly during axonal transport to the neurohypophysis. The labelled products of this conversion (neurophysin, AVP, and OT) are released, in a Ca2+-dependent manner, from the posterior pituitary in response to depolarization by veratridine. Both the rates of biosynthesis and of processing of the precursors are greatly increased by increased functional activity (i.e. secretion) of the hypothalamo--neurohypophysial system.
D000818:Animals; D001127:Arginine Vasopressin / Q000378:metabolism*; D001370:Axonal Transport / Q000187:drug effects; D002118:Calcium / Q000494:pharmacology; D003545:Cysteine / Q000378:metabolism*; D005260:Female; D008970:Molecular Weight; D009481:Neurophysins / Q000378:metabolism*; D010121:Oxytocin / Q000378:metabolism*; D010286:Paraventricular Hypothalamic Nucleus / Q000378:metabolism; D010904:Pituitary Gland, Posterior / Q000378:metabolism*; D051381:Rats; D013495:Supraoptic Nucleus / Q000378:metabolism; D014882:Water-Electrolyte Balance / Q000187:drug effects
D009481:Neurophysins; D001127:Arginine Vasopressin; D010121:Oxytocin; D003545:Cysteine; D002118:Calcium